US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Drugs Made In America Acquisition Corp

10.53

-0.0100-0.09%

Volume:271.91K

Turnover:2.87M

Market Cap:355.04M

PE:59.83

High:10.54

Open:10.54

Low:10.53

Close:10.54

52wk High:10.55

52wk Low:10.03

Shares:33.72M

Float Shares:23.41M

Volume Ratio:0.43

T/O Rate:1.16%

Dividend:- -

Dividend Rate:- -

EPS(TTM):0.1760

EPS(LYR):-0.0560

ROE:--

ROA:-1.46%

PB:1.57

PE(LYR):-188.14

Loading ...

Overview Company News Filings

Drugs Made in America Acquisition II posts FY25 net income of $4.2 million

Drugs Made in America Acquisition Corp Says Deal Anticipated to Value Power Analytics Global Corp at $1.0 Bln - SEC Filing

THOMSON REUTERS

Drugs Made In America Acquisition signs LOI to merge with Power Analytics Global at $1 billion valuation

Drugs Made in America Acquisition II issues $1.4 million convertible notes financing deal

Drugs Made in America Acquisition II delays annual report filing, targets April 15 deadline

Drugs Made In America Acquisition Corp. announced an extraordinary general meeting

Drugs Made In America Acquisition issued $100,000 interim convertible note to BV Advisory Partners; financing grows toward contemplated $500,000 total

Drugs Made in America Acquisition II Corp. signs USD 150,000 unsecured convertible bridge note with Alpha Multi Family Office

Drugs Made In America Acquisition Corp. Confirms $241.3 Million in Trust Account

Drugs Made In America Acquisition names Roger Bendelac CEO after Lynn Stockwell resigns

Drugs Made in America Acquisition Corp - on Nov 17, Appointed Saleem Elmasri as Chief Financial Officer - SEC Filing

THOMSON REUTERS

Drugs Made In America Acquisition Corp. Appoints Saleem Elmasri as Chief Financial Officer

Drugs Made In America Acquisition Corp. Delays Quarterly Financial Report

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/DMAA/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"DMAA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"DMAA\",,,,,undefined,":{"symbol":"DMAA","market":"US","secType":"STK","nameCN":"Drugs Made In America Acquisition Corp","latestPrice":10.53,"timestamp":1776456000000,"preClose":10.54,"halted":0,"volume":271907,"delay":0,"changeRate":-0.0009487666034155396,"floatShares":23405912,"shares":33717143,"eps":0.176,"marketStatus":"Market Closed","change":-0.01,"latestTime":"04-17 16:00:00 EDT","open":10.54,"high":10.54,"low":10.53,"amount":2865291.1354,"amplitude":0.000949,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.176,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1776672000000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":10.54,"preHourTrading":{"tag":"盘前","latestPrice":10.436,"preClose":10.54,"latestTime":"07:47 EDT","volume":36,"amount":375.696,"timestamp":1776426424597,"change":-0.104,"changeRate":-0.009867,"amplitude":0},"volumeRatio":0.4297852646882485},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"DMAA\",,,,,undefined,":{"symbol":"DMAA","floatShares":23405912,"roa":"-1.46%","roe":"--","lyrEps":-0.055968,"volumeRatio":0.4297852646882485,"shares":33717143,"dividePrice":0,"high":10.54,"amplitude":0.000949,"preClose":10.54,"low":10.53,"week52Low":10.03,"pbRate":"1.57","week52High":10.55,"institutionHeld":0,"latestPrice":10.53,"eps":0.176,"divideRate":0,"volume":271907,"delay":0,"ttmEps":0.176,"open":10.54,"prevYearClose":10.3742,"prevWeekClose":10.51,"prevMonthClose":10.48,"prevQuarterClose":10.48,"fiveDayClose":10.51,"twentyDayClose":10.47,"sixtyDayClose":10.43},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/DMAA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-04-15","symbol":"DMAA","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1776225600000,"reportTimeType":"post","actualEps":null},{"date":"2025-11-18","symbol":"DMAA","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1763499600000,"name":null,"time":"Post Market","dateTimestamp":1763442000000,"actualEps":null},{"market":"US","date":"2025-08-14","symbol":"DMAA","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1755144000000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2025-05-20","symbol":"DMAA","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1747713600000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2025-03-31","symbol":"DMAA","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1743393600000,"reportTimeType":"post","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"DMAA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"DMAA\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/DMAA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"DMAA","date":"2026-04-17","current":59.829545,"percent":0.679487,"low":-5272.922078,"twenty":-717.524833,"median":-700.756969,"eighty":63.972725,"high":64.846367,"avg":-471.656814,"sd":524.031543,"marketCap":353270687},"quantilePoints":[{"date":"2025-01-10","current":-608.075079,"twenty":-608.075079,"median":-608.075079,"eighty":-608.075079,"marketCap":291714290},{"date":"2025-01-24","current":-5272.922078,"twenty":-1541.044479,"median":-608.075079,"eighty":-608.075079,"marketCap":2529600000},{"date":"2025-01-31","current":-425.873505,"twenty":-1541.044479,"median":-608.075079,"eighty":-425.745934,"marketCap":204306000},{"date":"2025-02-07","current":-426.936594,"twenty":-608.075079,"median":-426.511358,"eighty":-426.043599,"marketCap":204816000},{"date":"2025-02-14","current":-428.637537,"twenty":-608.075079,"median":-427.4894,"eighty":-426.086123,"marketCap":205632000},{"date":"2025-02-21","current":-429.488008,"twenty":-608.075079,"median":-428.127254,"eighty":-426.213694,"marketCap":206040000},{"date":"2025-02-28","current":-695.318062,"twenty":-642.693308,"median":-428.637537,"eighty":-426.426311,"marketCap":333567715},{"date":"2025-03-07","current":-697.410294,"twenty":-694.899616,"median":-429.062772,"eighty":-426.511358,"marketCap":334571430},{"date":"2025-03-14","current":-696.712883,"twenty":-696.294437,"median":-608.075079,"eighty":-426.7665,"marketCap":334236858},{"date":"2025-03-21","current":-698.805113,"twenty":-697.410294,"median":-608.075079,"eighty":-426.936594,"marketCap":335240572},{"date":"2025-03-28","current":-700.199934,"twenty":-697.689258,"median":-694.620652,"eighty":-427.446877,"marketCap":335909715},{"date":"2025-04-04","current":-700.058307,"twenty":-699.084077,"median":-694.969357,"eighty":-427.94015,"marketCap":335841772},{"date":"2025-04-11","current":-700.756969,"twenty":-700.114958,"median":-695.666767,"eighty":-428.144263,"marketCap":336176944},{"date":"2025-04-17","current":-700.756969,"twenty":-700.534155,"median":-696.712883,"eighty":-428.217404,"marketCap":336176944},{"date":"2025-04-25","current":-702.852952,"twenty":-700.756969,"median":-697.061588,"eighty":-428.39005,"marketCap":337182458},{"date":"2025-05-02","current":-704.250274,"twenty":-701.315898,"median":-697.410294,"eighty":-428.637537,"marketCap":337852801},{"date":"2025-05-09","current":-706.346256,"twenty":-702.154292,"median":-697.758998,"eighty":-428.637537,"marketCap":338858315},{"date":"2025-05-16","current":-706.695588,"twenty":-703.691345,"median":-698.805113,"eighty":-428.977725,"marketCap":339025901},{"date":"2025-05-23","current":-707.743579,"twenty":-704.948934,"median":-699.780416,"eighty":-429.743149,"marketCap":339528658},{"date":"2025-05-30","current":-708.09291,"twenty":-705.647596,"median":-700.058307,"eighty":-465.715705,"marketCap":339696244},{"date":"2025-06-06","current":-709.839561,"twenty":-706.346256,"median":-700.199934,"eighty":-608.075079,"marketCap":340534172},{"date":"2025-06-13","current":-710.538223,"twenty":-706.975053,"median":-700.756969,"eighty":-608.075079,"marketCap":340869344},{"date":"2025-06-20","current":-711.935546,"twenty":-707.743579,"median":-700.756969,"eighty":-608.075079,"marketCap":341539687},{"date":"2025-06-27","current":-711.236883,"twenty":-707.743579,"median":-700.756969,"eighty":-608.075079,"marketCap":341204515},{"date":"2025-07-03","current":-711.935546,"twenty":-708.861436,"median":-701.106301,"eighty":-677.311537,"marketCap":341539687},{"date":"2025-07-11","current":-713.332868,"twenty":-709.979293,"median":-701.738587,"eighty":-694.620652,"marketCap":342210030},{"date":"2025-07-18","current":-714.730188,"twenty":-710.95742,"median":-702.154292,"eighty":-694.620652,"marketCap":342880372},{"date":"2025-07-25","current":-716.826172,"twenty":-711.236883,"median":-702.852952,"eighty":-694.620652,"marketCap":343885887},{"date":"2025-08-01","current":-717.524833,"twenty":-711.935546,"median":-704.250274,"eighty":-695.17858,"marketCap":344221058},{"date":"2025-08-08","current":-717.524833,"twenty":-712.005412,"median":-704.948934,"eighty":-695.318062,"marketCap":344221058},{"date":"2025-08-15","current":-718.223495,"twenty":-713.332868,"median":-705.647596,"eighty":-695.597026,"marketCap":344556230},{"date":"2025-08-22","current":-717.524833,"twenty":-714.17126,"median":-706.342764,"eighty":-695.945732,"marketCap":344221058},{"date":"2025-08-29","current":-716.365056,"twenty":-714.86992,"median":-706.346256,"eighty":-696.573401,"marketCap":343664674},{"date":"2025-09-05","current":-716.826172,"twenty":-716.222528,"median":-706.695588,"eighty":-696.712883,"marketCap":343885887},{"date":"2025-09-12","current":-716.12751,"twenty":-716.48802,"median":-707.044919,"eighty":-696.712883,"marketCap":343550715},{"date":"2025-09-19","current":-718.223495,"twenty":-716.826172,"median":-707.743579,"eighty":-697.13133,"marketCap":344556230},{"date":"2025-09-26","current":-718.132667,"twenty":-716.826172,"median":-707.743579,"eighty":-697.410294,"marketCap":344512657},{"date":"2025-10-03","current":-717.524833,"twenty":-716.826172,"median":-708.09291,"eighty":-697.410294,"marketCap":344221058},{"date":"2025-10-10","current":-718.223495,"twenty":-717.52064,"median":-708.966236,"eighty":-697.410294,"marketCap":344556230},{"date":"2025-10-17","current":-720.319477,"twenty":-717.524833,"median":-709.839561,"eighty":-697.410294,"marketCap":345561744},{"date":"2025-10-24","current":-720.668808,"twenty":-717.524833,"median":-710.538223,"eighty":-697.828739,"marketCap":345729330},{"date":"2025-10-31","current":-721.018137,"twenty":-717.524833,"median":-710.887554,"eighty":-698.526149,"marketCap":345896915},{"date":"2025-11-07","current":-720.494143,"twenty":-717.524833,"median":-711.236883,"eighty":-698.805113,"marketCap":345645537},{"date":"2025-11-14","current":-721.018137,"twenty":-718.219302,"median":-711.236883,"eighty":-698.805113,"marketCap":345896915},{"date":"2025-11-21","current":63.492837,"twenty":-718.223495,"median":-711.236883,"eighty":-698.805113,"marketCap":345896915},{"date":"2025-11-28","current":63.554362,"twenty":-718.223495,"median":-711.236883,"eighty":-697.410294,"marketCap":346232087},{"date":"2025-12-05","current":63.554362,"twenty":-718.2207,"median":-711.236883,"eighty":-696.991847,"marketCap":346232087},{"date":"2025-12-12","current":63.738934,"twenty":-718.182971,"median":-710.538223,"eighty":-695.806249,"marketCap":347237601},{"date":"2025-12-19","current":63.738934,"twenty":-717.889533,"median":-709.839561,"eighty":-694.620652,"marketCap":347237601},{"date":"2025-12-26","current":63.800458,"twenty":-717.524833,"median":-709.839561,"eighty":-625.384194,"marketCap":347572772},{"date":"2026-01-02","current":63.826298,"twenty":-717.524833,"median":-708.79157,"eighty":-608.075079,"marketCap":347713544},{"date":"2026-01-09","current":63.861982,"twenty":-717.524833,"median":-707.918244,"eighty":-428.637537,"marketCap":347907944},{"date":"2026-01-16","current":63.98503,"twenty":-717.524833,"median":-707.743579,"eighty":-428.042207,"marketCap":348578287},{"date":"2026-01-23","current":64.231126,"twenty":-717.524833,"median":-707.743579,"eighty":-426.851547,"marketCap":349918972},{"date":"2026-01-30","current":64.231126,"twenty":-717.524833,"median":-707.044919,"eighty":-426.086123,"marketCap":349918972},{"date":"2026-02-06","current":64.169602,"twenty":-717.524833,"median":-706.695588,"eighty":-327.489953,"marketCap":349583801},{"date":"2026-02-13","current":64.200364,"twenty":-717.524833,"median":-706.346256,"eighty":63.554362,"marketCap":349751387},{"date":"2026-02-20","current":64.169602,"twenty":-717.524833,"median":-706.342764,"eighty":63.554608,"marketCap":349583801},{"date":"2026-02-27","current":64.477223,"twenty":-717.524833,"median":-705.647596,"eighty":63.67741,"marketCap":351259658},{"date":"2026-03-06","current":64.538747,"twenty":-717.524833,"median":-704.948934,"eighty":63.738934,"marketCap":351594830},{"date":"2026-03-13","current":64.415699,"twenty":-717.524833,"median":-704.250274,"eighty":63.738934,"marketCap":350924487},{"date":"2026-03-20","current":64.415699,"twenty":-717.524833,"median":-702.852952,"eighty":63.76908,"marketCap":350924487},{"date":"2026-03-27","current":64.661795,"twenty":-717.524833,"median":-702.154292,"eighty":63.800458,"marketCap":352265172},{"date":"2026-04-02","current":64.600271,"twenty":-717.524833,"median":-702.021545,"eighty":63.826298,"marketCap":351930001},{"date":"2026-04-10","current":64.692557,"twenty":-717.524833,"median":-701.280966,"eighty":63.861982,"marketCap":352432758},{"date":"2026-04-17","current":59.466742,"twenty":-717.524833,"median":-700.756969,"eighty":63.972725,"marketCap":353270687}],"updateTime":1776508147429},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"DMAA\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2627923779","title":"Drugs Made in America Acquisition II posts FY25 net income of $4.2 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2627923779","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627923779?lang=en_us&edition=fundamental","pubTime":"2026-04-16 04:11","pubTimestamp":1776283882,"startTime":"0","endTime":"0","summary":"Drugs Made in America Acquisition II posted net income of USD 4.2 million for fiscal 2025, driven by USD 4.9 million of interest earned on cash and investments held in the trust account.Revenue was not reported, as the SPAC had not generated operating revenues to date.General and administrative costs totaled USD 488,385, while a USD 812,113 provision for credit losses reflected a full reserve against amounts due from the sponsor.Management said conditions raised substantial doubt about its ability to continue as a going concern within one year after the financial statements are issued.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Drugs Made in America Acquisition II Corp. published the original content used to generate this news brie","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260415:nNDL3vSnT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DMIIU","DMAA","DMII"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625448429","title":"Drugs Made in America Acquisition Corp Says Deal Anticipated to Value Power Analytics Global Corp at $1.0 Bln - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2625448429","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625448429?lang=en_us&edition=fundamental","pubTime":"2026-04-08 21:03","pubTimestamp":1775653401,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260408:nFWN40R0LJ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["DMAA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625941027","title":"Drugs Made In America Acquisition signs LOI to merge with Power Analytics Global at $1 billion valuation","url":"https://stock-news.laohu8.com/highlight/detail?id=2625941027","media":"Reuters","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625941027?lang=en_us&edition=fundamental","pubTime":"2026-04-08 21:01","pubTimestamp":1775653313,"startTime":"0","endTime":"0","summary":"Drugs Made in America Acquisition entered a letter of intent on April 7, 2026 to pursue a de-SPAC deal with Power Analytics Global.Proposed transaction would take Power Analytics Global public.Target valuation expected at about $1 billion, subject to due diligence and adjustments for capital structure, net debt, working capital, and market conditions.Parties expect to negotiate and sign a definitive business combination agreement.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Drugs Made In America Acquisition Corp. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 08, 2026, and is so","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260408:nNDLLFmq6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DMAA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624968664","title":"Drugs Made in America Acquisition II issues $1.4 million convertible notes financing deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2624968664","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624968664?lang=en_us&edition=fundamental","pubTime":"2026-04-04 04:34","pubTimestamp":1775248467,"startTime":"0","endTime":"0","summary":"Drugs Made in America Acquisition II entered into a definitive investment agreement on March 24, 2026 for a contemplated convertible notes financing.Company issued an interim convertible note of USD 0.3 million on March 30, 2026 to Alpha Multi Family Office.Note matures nine months from issuance, carries no interest.Investor can convert principal at business combination into shares at 35% discount to market price at conversion.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Drugs Made in America Acquisition II Corp. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 03, 2026, and is so","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260403:nNDLWvCKf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DMIIU","DMAA","DMII"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624549999","title":"Drugs Made in America Acquisition II delays annual report filing, targets April 15 deadline","url":"https://stock-news.laohu8.com/highlight/detail?id=2624549999","media":"Reuters","labels":["dataReport","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624549999?lang=en_us&edition=fundamental","pubTime":"2026-04-02 04:06","pubTimestamp":1775073978,"startTime":"0","endTime":"0","summary":"Drugs Made in America Acquisition II reported it will miss deadline for its Form 10-K for fiscal year ended Dec. 31, 2025.Delay was attributed to inability to compile all information needed for financial statements and related disclosures without unreasonable effort or expense.Filing indicated no anticipated significant change in results of operations versus prior-year period.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Drugs Made in America Acquisition II Corp. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 01, 2026, and is solely responsible for the information contained there","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260401:nNDL5bnzTr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DMII","DMAA","DMIIU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622036308","title":"Drugs Made In America Acquisition Corp. announced an extraordinary general meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2622036308","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622036308?lang=en_us&edition=fundamental","pubTime":"2026-03-28 04:58","pubTimestamp":1774645138,"startTime":"0","endTime":"0","summary":"Drugs Made In America Acquisition will hold an extraordinary general meeting in New York in April 2026.Shareholders will vote on a charter amendment to extend the deadline to complete a business combination from April 29, 2026 to a date in 2027, in up to one-month increments.A separate proposal will seek approval to adjourn the meeting to a later date if needed to continue soliciting votes on the extension.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Drugs Made In America Acquisition Corp. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 27, 2026, and is solely responsible for the","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260327:nNDL6CzvlP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DMAA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622870099","title":"Drugs Made In America Acquisition issued $100,000 interim convertible note to BV Advisory Partners; financing grows toward contemplated $500,000 total","url":"https://stock-news.laohu8.com/highlight/detail?id=2622870099","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622870099?lang=en_us&edition=fundamental","pubTime":"2026-03-28 04:08","pubTimestamp":1774642083,"startTime":"0","endTime":"0","summary":"Drugs Made In America Acquisition issued $100,000 interim convertible note to BV Advisory Partners; financing grows toward contemplated $500,000 total. The note matures six months after issuance unless earlier converted or credited toward a contemplated USD 500,000 financing under a separate investment agreement.Upon completion of an initial business combination, BV Advisory Partners may convert the outstanding principal into shares at a conversion price set at a 35% discount to the market price at conversion.Proceeds are intended for accounting and audit expenses and other business combination-related costs.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Drugs Made In America Acquisition Corp. published the original content used to ge","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260327:nNDLbMsKSw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DMAA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620803408","title":"Drugs Made in America Acquisition II Corp. signs USD 150,000 unsecured convertible bridge note with Alpha Multi Family Office","url":"https://stock-news.laohu8.com/highlight/detail?id=2620803408","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620803408?lang=en_us&edition=fundamental","pubTime":"2026-03-18 04:02","pubTimestamp":1773777749,"startTime":"0","endTime":"0","summary":"Drugs Made in America Acquisition II Corp. signs USD 150,000 unsecured convertible bridge note with Alpha Multi Family Office. Drugs Made in America Acquisition II issued an unsecured convertible bridge note to Alpha Multi Family Office with principal of 150,000. The note matures nine months after issuance and does not bear interest. Upon completion of the company’s initial business combination, the investor may convert the outstanding principal into shares at a 35% discount to the market price at conversion. Proceeds are intended for accounting and audit expenses related to the business combination.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Drugs Made in America Acquisition II Corp. published the original content used to generate","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260317:nNDL7hhMTg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DMIIU","DMAA","DMII"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617925653","title":"Drugs Made In America Acquisition Corp. Confirms $241.3 Million in Trust Account","url":"https://stock-news.laohu8.com/highlight/detail?id=2617925653","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617925653?lang=en_us&edition=fundamental","pubTime":"2026-03-07 06:02","pubTimestamp":1772834530,"startTime":"0","endTime":"0","summary":"Drugs Made In America Acquisition Corp. issued a clarification stating that after learning of improper withdrawals from an affiliate’s working capital account, its board acted to confirm the issue did not affect the company’s trust account. The company said that as of March 6, 2026, approximately $241,292,436 remains in its trust account.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Drugs Made In America Acquisition Corp. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 06, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260306:nNDL9LyZs:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DMAA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617870639","title":"Drugs Made In America Acquisition names Roger Bendelac CEO after Lynn Stockwell resigns","url":"https://stock-news.laohu8.com/highlight/detail?id=2617870639","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617870639?lang=en_us&edition=fundamental","pubTime":"2026-03-06 23:15","pubTimestamp":1772810110,"startTime":"0","endTime":"0","summary":"Drugs Made In America Acquisition Corp. said CEO and Executive Chair Lynn Stockwell resigned and was removed from the board, effective Feb. 28, 2026. The company appointed Roger Bendelac as CEO effective the same date. Bendelac, 69, has more than 30 years of experience in investment banking and corporate advisory work.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Drugs Made In America Acquisition Corp. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 06, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260306:nNDL2Nkk3V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DMAA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2584939370","title":"Drugs Made in America Acquisition Corp - on Nov 17, Appointed Saleem Elmasri as Chief Financial Officer  - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2584939370","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584939370?lang=en_us&edition=fundamental","pubTime":"2025-11-18 19:04","pubTimestamp":1763463890,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251118:nFWN3WU026:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["DMAA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2584493939","title":"Drugs Made In America Acquisition Corp. Appoints Saleem Elmasri as Chief Financial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2584493939","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584493939?lang=en_us&edition=fundamental","pubTime":"2025-11-18 19:02","pubTimestamp":1763463776,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Drugs Made In America Acquisition Corp. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 18, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251118:nNDL4D1bNt:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DMAA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2584647313","title":"Drugs Made In America Acquisition Corp. Delays Quarterly Financial Report","url":"https://stock-news.laohu8.com/highlight/detail?id=2584647313","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584647313?lang=en_us&edition=fundamental","pubTime":"2025-11-17 19:26","pubTimestamp":1763378796,"startTime":"0","endTime":"0","summary":"Drugs Made In America Acquisition Corp. has disclosed a delay in filing its quarterly financial report for the period ended September 30, 2025. The company notified the SEC that it was unable to file its Form 10-Q on time but expects to submit the report within the allowed extension period.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Drugs Made In America Acquisition Corp. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 17, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251117:nNDL959wd4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DMAA"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":13,"code":"91000000","status":"200"}]}}